November 2022
1. MAHDI A, Wodaje T, Kovamees O, Tengbom J, et al
   The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia.
   J Intern Med. 2022 Nov 2. doi: 10.1111/joim.13580.
   

   >> Share

   
   October 2022
2. ABIFADEL M, Boileau C
   Genetic and molecular architecture of familial hypercholesterolemia.
   J Intern Med. 2022 Oct 4. doi: 10.1111/joim.13577.
   

   >> Share

   
   December 2021
3. BARAGETTI A, Casula M, Scarinzi P, Riste F, et al
   Achilles tendon ultrasonography in familial hypercholesterolemia: A sub-study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN).
   J Intern Med. 2021 Dec 7. doi: 10.1111/joim.13421.
   

   >> Share

   
   October 2021
4. VUORIO A, Kovanen PT
   Mucormycosis and glucose-regulated protein 78 in COVID-19: Amenable to statin treatment?
   J Intern Med. 2021;290:931-933.
   

   >> Share

   
   September 2021
5. CHRISTENSEN JJ, Narverud I, Ruuth M, Heier M, et al
   Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross-sectional study.
   J Intern Med. 2021 Sep 10. doi: 10.1111/joim.13383.
   

   >> Share

   
   May 2021
6. BENEDEK P, Jiao H, Duvefelt K, Skoog T, et al
   Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
   J Intern Med. 2021 May 6. doi: 10.1111/joim.13287.
   

   >> Share

   
   November 2020
7. VUORIO A, Kovanen PT
   PCSK9 inhibitors for COVID-19: An opportunity to enhance the antiviral action of interferon in patients with hypercholesterolemia.
   J Intern Med. 2020 Nov 21. doi: 10.1111/joim.13210.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share